



TECHNICAL ACTIVITIES 1998 -
NISTIR 6268
MISSION
ORGANIZATION
CURRENT DIRECTIONS
TECHNICAL HIGHLIGHTS
FUTURE DIRECTIONS
FUTURE DIRECTIONS
- Brachytherapy Dosimetry. An estimated 60,000 brachytherapy
procedures are currently performed annually in the U.S., with a significant
growth seen for low-energy photon brachytherapy (125I and
103Pd) in prostate cancer treatment. Moreover, there is the
potential for brachytherapy to increase to some 500,000 procedures per year
with the advent of intravascular brachytherapy in the treatment of heart
disease. Critical to the assurance of absorbed dose in such procedures is
traceability to national standards. Early leadership in the dosimetry of
beta-emitting brachytherapy sources should be extended toward development of a
coherent program for the measurement of absorbed dose in water or tissue for
all such sources, including photon-emitting radionuclides.
- Industrial High-Energy Computed Tomography. The MIRF electron
linear accelerator should provide an adequate source as a test bed for
high-energy CT applications. With past and current experience applications in
low- and high-energy CT, the establishment of capabilities at MIRF would
provide a valuable resource to pursue collaborations in innovative areas such
as studies of the solidification front in metal castings, a subject for which
we have been approached. The construction of a high-energy x-ray camera system
will help position us to contribute in such studies.
- Industrial and Therapy Electron-Beam Dosimetry Calibrations with
EPR. Radiation processing by electron beams with energies from about
0.1 MeV to 25 MeV is carried out in an estimated 700-1000
facilities, with such use on an increasing path. For therapy applications,
NIST maintains a measurement quality assurance program for electron beams with
energies from about 6 MeV to 20 MeV, based on Fricke dosimetry. With
the MIRF electron accelerator capable of beam energies of 7 MeV to
32 MeV and the electron Van de Graaff with energies from 1 to 4 MeV,
NIST has the resources to address the need for the direct electron-beam
calibrations and traceable reference measurement services for much of the
range involved in industrial processing and in therapy. Initial work with
graphite calorimetry in MIRF electron beams shows promise for the development
of absolute dosimetry measurements for high-energy electron beams, and their
transfer to alanine/EPR dosimetry systems. Early field tests indicate the
suitability of alanine/EPR dosimetry as a replacement for Fricke dosimetry in
our therapy electron-beam measurements. Continued development should promote
further maturity in the use of alanine/EPR systems as transfer dosimeters,
including such important electron-beam applications.
- Magnetically Trapped Ultra Cold Neutrons. In collaboration with
physicists at Harvard University an Ultra Cold Neutron (UCN) experiment
is planned, based on "superthermal" cooling of neutrons with wavelength
0.89 nm to the ultra cold neutron energy range by exchange of a single
phonon (per neutron) in a superfluid bath of liquid helium. The initial
application of this UCN source will be a neutron lifetime experiment with
potential improvement in accuracy of better than a factor of 10 compared to
the present best value.
- Neutron Tomography. Recent improvements in CCD imaging systems and
the widespread availability of computed tomography (CT) and 3D image
reconstruction software have made it possible to set up a neutron CT imaging
system with only modest resources. Neutron CT imaging can complement x-ray CT
scans, by providing higher sensitivity to hydrogen, boron, lithium and certain
other elements and isotopes in many important industrial applications.
- Laser Polarization of Neutrons. Commercial developments in the
production of inexpensive diode lasers may make laser polarization of neutrons
by spin exchange the method of choice for both materials science and neutron
physics experiments. However, research in non-perturbing compression of low
density polarized 3He from direct optical pumping of metastable
3He may lead to an even less expensive method. Both possibilities
are being pursued. The application of laser-polarized inert gases to medical
magnetic resonance imaging is also being investigated through collaborations
with the University of Pennsylvania, the University of Nottingham, and the
University of Virginia.
- Development and Calibration of Very Low-Level Measurement
Techniques. (i) A fast, inexpensive method for atom counting based
on Resonance Ionization Mass Spectrometry will continue to be developed.
Although much progress in this program has been made, the sensitivity must be
improved by increasing the duty cycle. A Ti(Saph) laser is being adapted for
this application. (ii) The Nuclear Regulatory Commission is moving toward
increasing sensitivity requirements for in situ measurements of
radioactivity by a factor of 10 from that which can be attained by the present
Ge-based systems. NIST will investigate and develop imaging plate technology
for the measurement of very low level activities in site remediation, in
breakdown in microchips by alpha particle contaminants and other areas.
- Development of New Standards for Nuclear Medicine. National
laboratories, universities, and radiopharmaceutical companies report that they
are investigating about three dozen potential radiopharmaceuticals. In many
cases, the decay scheme and calibration data are suspect. In order to
facilitate licensing of these materials, NIST must provide the necessary
calibration data and accompanying measurements prior to Food and Drug
Administration approval. The Radioactivity Group will continue to collaborate
with researchers in the early phases of radiopharmaceutical development to
hopefully decrease the amount of time necessary to complete the approval
process.
- National and International Intercomparisons in Radioactivity
Measurements. Foreign and domestic National laboratories, in order to
maintain the highest possible accuracy of radioactive measurements, must
periodically intercompare methods and data related to radioactivity
measurements. The Radioactivity Group will continue to participate in a number
of national and international intercomparisons in environmental radioactivity
metrology and nuclear medicine metrology. In environmental metrology we are
working on measurements of 40K, 90Sr, 137Cs,
226Ra, 228Ra, 228Th, 230Th,
232Th, 238Pu, and 239-240Pu with
20 laboratories worldwide and, through our Radiochemistry Intercomparison
Program, NRIP, we are working with eight domestic laboratories to meet the
demand for traceability. In nuclear medicine metrology we are working on
international intercomparisons of 133Xe; recalibration of
3H for international intercomparisons; and submission of standards
to the BIPM/SIR program. We continue with our efforts to assist other agencies
and private industry to fulfill consensus standards which call for
traceability testing programs linking the quality of operational measurements
to the national standards.
- Low-level Radiochemistry Metrology. Many tens of thousands of
low-level radiochemical measurements are made annually to support
environmental remediation and occupational health programs. To provide
infrastructure support for these programs, NIST will focus its efforts into
three areas: 1) natural matrix standard reference materials;
2) radionuclide speciation in soils and sediments; and
3) measurement traceability testing. The natural matrix SRM project has
certified actinides, and fission and activation radionuclides in soils,
fresh-water lake and river sediments, human tissues, and ocean sediment, and
is working on additional unique matrices: ashed bone, ocean shellfish, and
Rocky Flats Soil-II. A standard protocol for the determination of radionuclide
partitioning among geophysical/chemical soil and sediment phases for
environmental remediation studies is being developed for future
characterization of a new family of radionuclide SRMs. The NIST Radiochemistry
Intercomparison Program (NRIP) has recently been initiated to provide
traceability testing of laboratories engaged in low-level radiobioassay and
environmental radionuclide monitoring and remediation.
Mission | Organization | Current Directions | Technical Highlights |
Future Directions
TECHNICAL ACTIVITIES 1998
- Contents

Pages designed and maintained by the Office of ECSED.
Inquiries or comments: Feedback.
Online: April 1999